The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes.
EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...
Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart ...
The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...
As of January, California is the first state in the country to partner with a nonprofit to develop, produce and sell its own ...
Abstract: Effective management of pediatric diabetes remains a clinical challenge, particularly due to the onset of lipodystrophy resulting from repeated insulin injections and inadequate rotation of ...
From higher wages and cheaper insulin to paper-only grocery bags and expanded renter protections, hundreds of new California laws are set to reshape daily life beginning in January. Nearly 800 new ...
EXPECTING SOME FREEZING TEMPERATURES TO START ROLLING IN SCOTT. I FEEL LIKE THIS HAS TO BE THE BUZZ AT EVERY BREAK ROOM AT WORK THIS WEEK. HAVE YOU HEARD ABOUT THE COLD WEATHER THAT’S COMING? LOOK AT ...
NEW YORK — Federal prosecutors said CVS Pharmacy will pay $37.76 million to resolve accusations that the company repeatedly dispensed more insulin to patients than their prescriptions required and ...
Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes had a higher time in range if they usually administered bolus insulin after a missed ...
The settlement resolves allegations that, from 2010 through 2020, CVS violated the False Claims Act in connection with its billing and dispensing of insulin pens to patients enrolled in government ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results